Targeting tumor O‐glycosylation modulates cancer–immune‐cell crosstalk and enhances anti‐<scp>PD</scp>‐1 immunotherapy in head and neck cancerMei‐Chun Lin(National Taiwan University Hospital), Pei‐Jen Lou(National Taiwan University)Molecular OncologyJuly 15, 202310.1002/1878-0261.13489Cited by 15SaveCiteExport RISWatch citationsRelated PapersC1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer|Oncogene|2018|67